Jiangsu Apon Medical Technology Co Ltd Class A (300753) — Capital Reinvestment Ratio
Jiangsu Apon Medical Technology Co Ltd Class A (300753) has a Capital Reinvestment Ratio of 0.11x as of December 2024, meaning it reinvests 0% of its operating cash flow (CN¥49.02 Million) in capital expenditures (CN¥5.48 Million). Check 300753 goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Jiangsu Apon Medical Technology Co Ltd Class A Capital Reinvestment Ratio (2014–2024)
This chart tracks Jiangsu Apon Medical Technology Co Ltd Class A's Capital Reinvestment Ratio across 9 annual periods. For the full cash flow conversion analysis, see 300753 operating cash flow.
Annual Capital Reinvestment Ratio for Jiangsu Apon Medical Technology Co Ltd Class A (2014–2024)
Year-by-year Capital Reinvestment Ratio for Jiangsu Apon Medical Technology Co Ltd Class A from 2014 to 2024. See 300753 free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.65x | CN¥15.68 Million | CN¥10.23 Million | ▼ -69.9% |
| 2021 | 2.17x | CN¥18.29 Million | CN¥39.60 Million | ▲ +406.5% |
| 2020 | 0.43x | CN¥83.34 Million | CN¥35.64 Million | ▼ -43.1% |
| 2019 | 0.75x | CN¥77.59 Million | CN¥58.33 Million | ▼ -4.6% |
| 2018 | 0.79x | CN¥78.13 Million | CN¥61.59 Million | ▲ +237.5% |
| 2017 | 0.23x | CN¥67.08 Million | CN¥15.66 Million | ▲ +229.1% |
| 2016 | 0.07x | CN¥60.97 Million | CN¥4.33 Million | ▼ -12.8% |
| 2015 | 0.08x | CN¥38.08 Million | CN¥3.10 Million | ▲ +2.4% |
| 2014 | 0.08x | CN¥33.49 Million | CN¥2.66 Million | — |